Innovent Biologics HK$4.65 billion share placement
Davis Polk advised the sole placing agent for the placement of 56,200,000 new shares and 36,800,000 existing shares in Innovent Biologics, Inc., for an aggregate consideration of…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
CIFI Holdings (Group) $300 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $300 million Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 5.950% senior notes due 2025.
Established in 2000…
Trip.com $500 million exchangeable senior notes offering
Davis Polk advised the initial purchasers in a Regulation S offering by Trip.com Group Limited of $500 million aggregate principal amount of 1.500% exchangeable senior notes due 2027…
RiseSun Real Estate Development $250 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with the Regulation S offering of $250 million principal amount of 9.000% senior notes due 2021 by RongXingDa Development (BVI)…
Golden Wheel Tiandi $170 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $170 million Regulation S offering by Golden Wheel Tiandi Holdings Limited of its 14.250% senior notes due 2023.
Golden Wheel…
Ocumension Therapeutics HK$1.55 billion IPO and HKEX listing
Davis Polk advised the underwriters in the initial public offering of Ocumension Therapeutics on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule…
Shenzhen Hepalink Pharmaceutical Group HK$4.05 billion IPO
Davis Polk advised Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering…
New Oriental Education & Technology Group debut $300 million bond offering
Davis Polk advised the joint lead managers in connection with the debut offering of $300 million 2.125% bonds due 2025 issued by New Oriental Education & Technology Group Inc.
New…
Genetron Holdings $256 million IPO
Davis Polk advised Genetron Holdings Limited on its SEC-registered initial public offering of 16,000,000 American Depositary Shares. Each ADS represents five ordinary shares. Genetron has…
Ronshine China Holdings $250 million high-yield notes offering
Davis Polk advised the initial purchasers on the Regulation S offering of high-yield notes by Ronshine China Holdings Limited of $250 million principal amount of 7.350% senior notes due…